Requests similar to 'COVID19 proof of scientific isolation'
MHRA and Bill Gates grants
Response by Medicines and Healthcare Products Regulatory Agency to ANNA Frances on .
Partially successful
FOI 21/358
Dear AMCBA,
Thank you for your email.
Please find below the answers to the questions you have raised.
QUESTION: Please kindly provide...
Covid19 Vaccination Programme - Risk-Benefit Evidence
Response by Medicines and Healthcare Products Regulatory Agency to Bob Parkinson on .
Long overdue
Internal Review of FOI 21/374
Dear Bob Parkinson,
Thank you for your email.
Please find attached the response to your Internal Review...
PV Strategy Document, AESI spreadsheet, Pfizer case output files
Response by Medicines and Healthcare Products Regulatory Agency to D Jackson on .
Partially successful
Internal Review of FOI 22/912
Dear D Jackson,
Thank you for your email.
Please find attached the response and attached document to your Internal Rev...
Weekly hospitalisations from Adverse Reactions to the Coronavirus vaccines
Response by Medicines and Healthcare Products Regulatory Agency to Karl Rainer on .
Information not held
Dear Mr Rainer,
Please find the attached in response to your FOI request.
Kind regards,
FOI Team
Vigilance and Risk Management of Medici...
Fatalities from Covid19 vaccines
Response by Medicines and Healthcare Products Regulatory Agency to ANNA Frances on .
Successful
Our Ref: FOI 21/356
Dear AMCBA,
RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000
Thank you for your enquiry which we received on 6 April 20...
Test data and results for each batch of BNT162b2 independently tested by the NIBSC under Regulation 174A
Response by Medicines and Healthcare Products Regulatory Agency to Dr Lee Proctor on .
Awaiting classification
FOI 23/051
Dear Dr Lee Proctor,
Thank you for your email.
Please find attached the response to your FOI request.
Kind Regards...
Information on frameshifting
Response by Medicines and Healthcare Products Regulatory Agency to Clare Craig on .
Long overdue
Dear Claire,
Please find our response to your FOI.
Kind regards,
FOI Team
Email 1
From:
Sent: Wednesday, November 22, 2023...
Covid-19 vaccines and atrial fibrillation
Response by Medicines and Healthcare Products Regulatory Agency to Graham Crawley on .
Information not held
Dear Graham Crawley,
Please find attached a response to your FOI request.
Kind regards,
FOI Team
Vigilance and Risk Management of Medicines Division...
US DoD Medical Countermeasures
Response by Medicines and Healthcare Products Regulatory Agency to Dan Couzens on .
Successful
CEC 138383
Dear Mr Couzens,
Thank you for your email.
Please find below the answers to the questions you have raised below.
What level...
Covid-19 Vaccine and ingredients
Response by Medicines and Healthcare Products Regulatory Agency to Mr. B. Singh on .
Partially successful
Dear Mr Singh,
Please find attached the response to your FOI request.
Kind regards,
FOI Team
Vigilance and Risk Management of Medicines Division...
Pfizer’s Pregnancy & Lactation Cumulative Review document
Response by Medicines and Healthcare Products Regulatory Agency to Sonia Elijah on .
Awaiting classification
FOI 23/751
Dear Sonia Elijah
Thank you for your email.
Please find attached the response to your FOI request.
Kind Regards
MHRA Customer Experien...
Our Ref: FOI 22/605
Dear Mr/Ms Jackson,
Please see the attached response to your enquiry.
Kind Regards,
MHRA...
"Approval" of Moderna Vaccine "spikevax" for 12-17 year olds
Response by Medicines and Healthcare Products Regulatory Agency to Barbara Jones on .
Partially successful
Dear Barbara Jones,
Thank you for your email.
The temporary authorisations of the Pfizer/BioNTech, Oxford/AstraZeneca
and Moderna vaccines...
Antigenic imprinting following vaccination with Pfizer-BioNTech COVID-19 vaccine (Comirnaty/tozinameran)
Response by Medicines and Healthcare Products Regulatory Agency to Kenneth MacArthur on .
Information not held
Dear Mr MacArthur
Regarding your email of 28 October 2021, where you asked whether MHRA can
confirm whether we have “considered the matter o...
Contents of all the vaccines being used for Covid and the variants in England and Wales.
Response by Medicines and Healthcare Products Regulatory Agency to Jane McDonnell on .
Information not held
Thank you for your email. This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
W...
Pre-licensing consideration of antigenic imprinting following vaccination with Pfizer-BioNTech COVID-19 vaccine (Comirnaty/tozinameran)
Response by Medicines and Healthcare Products Regulatory Agency to Kenneth MacArthur on .
Information not held
Thank you for your email. This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
W...
Reports and Data to meet Conditions of Authorisation for Vaxzevria
Response by Medicines and Healthcare Products Regulatory Agency to CHP Gillow on .
Partially successful
Dear CHP Gillow
Please find attached the response to your delayed request FOI 23/105. Due
to the size of some of the attachments, I’ll send...
The “Miracle” cure for Covid-19 is here; confirmed by numerous scientific studies.
Response by Medicines and Healthcare Products Regulatory Agency to Roland Gilmore on .
Information not held
Dear Mr Gilmore,
Thank you for your email.
Regarding your specific statements:
Currently, there is no prophylaxis approved for the treatment of Covi...
Open letter from Doctors and Scientists to the European Medicines Agency regarding COVID-19 vaccine safety concerns
Response by Medicines and Healthcare Products Regulatory Agency to Craig Allen on .
Successful
Dear Graig Allen,
Thank you for your email.
Please find attached your internal review of FOI request 21/416.
If you were to remain di...
Immune system's response to pathogens following COVID-19 vaccination
Response by Medicines and Healthcare Products Regulatory Agency to Kenneth MacArthur on .
Refused
Internal Review of FOI 21/550
Dear Mr MacArthur,
Unfortunately, due to the number of Freedom of Information (FOI) requests
we have been re...
Vaccine deaths
Response by Medicines and Healthcare Products Regulatory Agency to Ian Dalton on .
Information not held
Dear Mr Dalton,
Please accept our apologies for the confusion relating to your query,
reference CSC 62932, where you asked “I would like to know how...
Oxford AZ Covid19 Vaccine Approval Data
Response by Medicines and Healthcare Products Regulatory Agency to A Wingrove on .
Awaiting classification
Thank you for your email. This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
W...
June Raine emails
Response by Medicines and Healthcare Products Regulatory Agency to Barbara Jones on .
Partially successful
FOI 22/745
Dear Ms Jones,
Thank you for your email.
Please find attached the response and documents to your FOI request.
Yours sincerely
MHRA Cust...
Covid Booster programme UK
Response by Medicines and Healthcare Products Regulatory Agency to Tricia McGuigan on .
Refused
Thank you for your email. This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
W...
Immunological phenomena in connection with vaccination with Pfizer-BioNTech COVID-19 vaccine (Comirnaty/tozinameran)
Response by Medicines and Healthcare Products Regulatory Agency to Kenneth MacArthur on .
Information not held
FOI 21/1343
Dear Kenneth MacArthur,
Thank you for your email of 21 December where you have asked “Please can
you confirm whether the MHRA...